Novo Nordisk is undergoing significant leadership changes, including the replacement of its chair and six independent directors, due to a strategic disagreement with the Novo Nordisk Foundation. The new appointees bring extensive experience from notable companies, aiming to bolster the company's strategic direction and revitalize sales.
Novo Nordisk Shakes Up Leadership Amid Strategic Dispute